Table 2.
Primary Limitations | Possible Solutions |
---|---|
Small sample size | -Multi-centric samples collections |
Heterogeneity in protocols | Expert consensus on the protocols |
Heterogeneity of the participants | Correct clinical classification should be validated by traditional techniques and genetic background should be taken into consideration while conducting analysis |
Expensive cost | Major laboratories should work on cost-effectiveness to get the easy penetration of the liquid biopsy test world-wide |